Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 124 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				NCCTG-784651

Last Modified: 4/12/2006


2.		Phase II/III Chemotherapy with FAP (5-FU/ADR/CACP) vs FAT (5-FU/ADR/TZT) vs FAMe (5-FU/ADR/MeCCNU) in Metastatic or Unexplored Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								GITSG-8380


3.		Phase II/III Chemotherapy with FAMe (5-FU/ADR/MeCCNU) with vs without Abdominal Radiotherapy for Unresectable or Local Residual Stage III/IV Gastric Carcinoma (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified								MAYO-804151 NCCTG-804151

Last Modified: 7/1/1990


4.		Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				18 and over				NCI				NCCTG-834151 MAYO-834151, NCCTG-83-41-51


5.		Phase II/III Combination Chemotherapy with MeFA (MeCCNU/5-FU/ADR) vs FA (ADR/5-FU) for Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 70								EORTC-40791

Last Modified: 5/9/2007


6.		Phase II - III Study of Chemotherapy with MeCCNU, SZC/CTX and SZC/5-FU for Advanced Unresectable Pancreatic Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-2272 MAYO-706013


7.		Phase II/III Chemotherapy with Combinations of MeCCNU, MITO, ADR and 5-FU for Advanced Measurable Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-2277


8.		Master Protocol for Phase II-III Chemotherapy for Pancreatic Carcinoma --- PALA vs SAM (STZ/ADR/MeCCNU)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-2279

Last Modified: 5/22/2007


9.		Phase II-III Study of Chemotherapy with ADR or 5-FU/MeCCNU or 5-FU/Mitomycin C for Advanced Gastric Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-3274 MAYO-706018

Last Modified: 5/21/2007


10.		Phase II and III Chemotherapy with 5-FU, CTX, TG, MeCCNU and TGDR for Advanced Colon and Rectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-4273

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute